109 results
Page 3 of 6
6-K
EX-99.1
3a7xnefjev7m 7n
20 May 21
BrainsWay Reports First Quarter 2021 Financial Results and Operational Highlights
8:00am
6-K
EX-99.1
povxu7203rxo8
5 May 21
BrainsWay Announces Appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer
8:00am
SC TO-I
EX-99
u8pijh7gylc3zay qnn
4 May 21
Issuer tender offer statement
9:28am
6-K
EX-99.1
l0mhoh4kbp0f kh8
26 Apr 21
BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder
7:30am
6-K
EX-99.1
9lvwe40hpeu 78
24 Mar 21
BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights
4:15pm
6-K
EX-99.1
kaqicdv4kpq framhpp
1 Mar 21
Current report (foreign)
7:00am
6-K
EX-1.1
6gxkx
25 Feb 21
Current report (foreign)
11:00am
424B5
mzn2jm
24 Feb 21
Prospectus supplement for primary offering
4:31pm
6-K
EX-99.1
q0v nns6qcps66jiw2
23 Feb 21
BrainsWay Ltd. Announces Pricing of $39,287,000 Underwritten Offering of American Depositary Shares
8:30am
424B5
9cace
22 Feb 21
Prospectus supplement for primary offering
5:08pm
6-K
EX-99.1
sumwawzd4
22 Feb 21
BrainsWay Ltd. Announces Proposed Public Offering of American Depositary Shares
4:02pm
6-K
EX-99.1
8ijxjugm im
16 Feb 21
BrainsWay Reports Preliminary Record Fourth Quarter Revenue and Full-Year 2020 Financial Results
7:00am
6-K
EX-99.1
qyeica5vzu3pq
18 Nov 20
BrainsWay Reports Third Quarter 2020 Financial Results and Operational Highlights
7:00am
F-3
m5l6ai tzndis0bvo
4 Sep 20
Shelf registration (foreign)
9:37am
6-K
EX-99.1
o12pv
24 Aug 20
BrainsWay Receives FDA Clearance for Smoking Addiction in Adults
7:01am
6-K
EX-99.1
wojlqf01yovv0uv4t5
12 Aug 20
BrainsWay Reports Second Quarter 2020 Financial Results and Operational Highlights
7:09am
6-K/A
EX-99.1
7e3xo 1vnfuzln
24 Jun 20
CORRECTION - BrainsWay Reports First Quarter 2020 Financial Results and Operational Highlights
5:26pm
6-K
EX-99.1
zic9ngcfcsc
24 Jun 20
BrainsWay Reports First Quarter 2020 Financial Results and Operational Highlights
7:30am